Brief: Rhinomed Says Revenue For FY22 Was A$9.1M (Unaudited)
28/07/2022 02:22
July 28 (Reuters) - Rhinomed Ltd RNO.AX :
* REVENUE FOR FY22 WAS A$9.1M (UNAUDITED), UP 134% ON FY21
Source text for Eikon: ID:nASX5m8tR0
Further company coverage: RNO.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhinomed
See all newsBrief: Rhinomed Says Q2 Revenues Of A$1.8M
Australia's Rhinomed hits record low after delisting and capital raise announcement
Brief: Rhinomed Formally Applies To ASX Requesting Removal From Official List
Brief: Rhinomed Ltd Seeks Trading Halt
Brief: Rhinomed Says It Is Implementing Measures To Reduce Cash Burn, Including Reduction In Headcount